Boryung puts out ARB antihypertensive agent

Boryung says it has launched its new antihypertensive medicine containing losartan kalium, angiotensin II antagonist, through its own formulation technology.

This medicine works by preventing the action of a hormone in the body called angiotensin II.

Losartan kalium blocks the receptors that angiotensin II acts on, and so prevents its actions. The main result of this is that the peripher...